| Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer R Tiwari, N Manzar, V Bhatia, A Yadav, MA Nengroo, D Datta, ... Nature Communications 11 (1), 384, 2020 | 70 | 2020 |
| Epigenetic silencing of miRNA-338-5p and miRNA-421 drives SPINK1-positive prostate cancer V Bhatia, A Yadav, R Tiwari, S Nigam, S Goel, S Carskadon, N Gupta, ... Clinical Cancer Research 25 (9), 2755-2768, 2019 | 60 | 2019 |
| SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression R Tiwari, SK Pandey, S Goel, V Bhatia, S Shukla, X Jing, ... Oncogenesis 4 (8), e162-e162, 2015 | 60 | 2015 |
| Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy V Bhatia, NV Kamat, TE Pariva, LT Wu, A Tsao, K Sasaki, H Sun, G Javier, ... Nature Communications 14 (1), 2041, 2023 | 37 | 2023 |
| Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression S Goel, V Bhatia, S Kundu, T Biswas, S Carskadon, N Gupta, M Asim, ... Nature communications 12 (1), 5325, 2021 | 30 | 2021 |
| Epigenetic reprogramming during prostate cancer progression: a perspective from development S Goel, V Bhatia, T Biswas, B Ateeq Seminars in cancer biology 83, 136-151, 2022 | 25 | 2022 |
| Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer E Sayar, RA Patel, IM Coleman, MP Roudier, A Zhang, P Mustafi, JY Low, ... JCI insight 8 (7), 2023 | 24 | 2023 |
| Direct intranuclear anticancer drug delivery via polydimethylsiloxane nanoparticles: in vitro and in vivo xenograft studies G Mishra, S Bhattacharyya, V Bhatia, B Ateeq, A Sharma, S Sivakumar ACS applied materials & interfaces 9 (40), 34625-34633, 2017 | 23 | 2017 |
| Molecular discriminators of racial disparities in prostate cancer B Ateeq, V Bhatia, S Goel Trends in cancer 2 (3), 116-120, 2016 | 12 | 2016 |
| Molecular underpinnings governing genetic complexity of ETS-fusion-negative prostate cancer V Bhatia, B Ateeq Trends in molecular medicine 25 (11), 1024-1038, 2019 | 10 | 2019 |
| „Herbal excipients: Pharmaceutical applications‟ S Khawnekar, V Bhatia, K Shashri, S Pandey International Journal of Pharmacognosy and Phytochemical Research 6 (3), 617-621, 2014 | 6 | 2014 |
| Correction: SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression R Tiwari, SK Pandey, S Goel, V Bhatia, S Shukla, X Jing, ... Oncogenesis 10 (2), 2021 | 2 | 2021 |
| Polycomb Group protein EZH2-mediated transcriptional repression of microRNA-338/-421 drives SPINK1-positive prostate cancer V Bhatia, A Yadav, R Tiwari, S Nigam, S Goel, S Carskadon, N Gupta, ... bioRxiv 1, 2018 | 2 | 2018 |
| A combinatorial genetic strategy for exploring complex genotype–phenotype associations in cancer S Li, A Wong, H Sun, V Bhatia, G Javier, S Jana, Q Wu, RB Montgomery, ... Nature Genetics 56 (3), 371-376, 2024 | 1 | 2024 |
| Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations S Li, A Wong, H Sun, V Bhatia, G Javier, S Jana, RB Montgomery, ... bioRxiv, 2023.04. 12.536652, 2023 | 1 | 2023 |
| Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell therapy V Bhatia, NV Kamat, TE Pariva, LT Wu, A Tsao, K Sasaki, LT Wiest, ... bioRxiv, 2022.05. 16.492156, 2022 | 1 | 2022 |
| Direct Intranuclear Anticancer Drug Delivery via Polydimethylsiloxane Nanoparticles: In Vitro and In Vivo Xenograft Studies (vol 9, pg 34625, 2017) G Mishra, S Bhattacharyya, V Bhatia, B Ateeq, A Sharma, S Sivakumar ACS APPLIED MATERIALS & INTERFACES 11 (42), 39395-39395, 2019 | 1 | 2019 |
| Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer R Tiwari, N Manzar, V Bhatia, A Yadav, S Carskadon, N Gupta, ... bioRxiv, 562652, 2019 | 1 | 2019 |
| PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity G Varuzhanyan, CC Chen, J Freeland, T He, W Tran, K Song, L Wang, ... bioRxiv, 2024.04. 09.588489, 2024 | | 2024 |
| 308 Harnessing tumor localized IL-12 to enhance STEAP1 CAR T cell therapy for prostate cancer V Bhatia, N Kamat, T Pariva, LT Wu, A Tsao, K Sasaki, L Wiest, A Zhang, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
